D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 15.3 CNY -5.9% Market Closed
Market Cap: 17.4B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
DaShenLin Pharmaceutical Group Co Ltd

Current Assets 11.5B
Cash & Short-Term Investments 2.8B
Receivables 1.9B
Other Current Assets 6.8B
Non-Current Assets 14B
Long-Term Investments 197.7m
PP&E 7.4B
Intangibles 5.4B
Other Non-Current Assets 911.6m
Current Liabilities 12.3B
Accounts Payable 3.1B
Accrued Liabilities 471.6m
Short-Term Debt 5.8B
Other Current Liabilities 2.9B
Non-Current Liabilities 6.1B
Long-Term Debt 4.8B
Other Non-Current Liabilities 1.3B

Balance Sheet
DaShenLin Pharmaceutical Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
603
527
668
1 081
712
1 180
3 271
2 247
3 776
2 997
Cash
0
1
0
0
0
1
0
2 247
3 776
2 997
Cash Equivalents
603
526
668
1 081
712
1 179
3 271
0
0
0
Short-Term Investments
0
0
0
680
100
904
890
109
92
42
Total Receivables
229
212
333
428
481
576
700
1 110
1 514
1 867
Accounts Receivables
105
111
207
247
277
356
432
739
1 017
1 216
Other Receivables
124
101
126
181
204
220
268
370
496
651
Inventory
756
1 010
1 305
1 717
1 886
2 055
2 683
3 630
3 872
4 181
Other Current Assets
100
67
97
149
847
754
752
772
1 415
1 711
Total Current Assets
1 688
1 816
2 404
4 055
4 025
5 468
8 297
7 868
10 670
10 798
PP&E Net
442
564
664
1 011
1 041
1 166
1 375
5 727
6 145
7 343
PP&E Gross
0
564
664
1 011
1 041
1 166
1 375
5 727
6 145
7 343
Accumulated Depreciation
0
125
165
226
323
447
597
3 199
3 709
4 261
Intangible Assets
50
64
67
114
288
385
539
676
701
1 880
Goodwill
14
14
126
162
534
984
1 334
2 060
2 364
3 024
Long-Term Investments
0
8
58
109
180
155
185
235
177
215
Other Long-Term Assets
171
194
261
372
469
514
602
770
786
864
Other Assets
14
14
126
162
534
984
1 334
2 060
2 364
3 024
Total Assets
2 365
N/A
2 658
+12%
3 580
+35%
5 823
+63%
6 537
+12%
8 672
+33%
12 332
+42%
17 336
+41%
20 841
+20%
24 123
+16%
Liabilities
Accounts Payable
509
586
752
901
884
1 312
1 651
2 053
2 772
2 746
Accrued Liabilities
128
132
179
211
262
339
448
500
827
765
Short-Term Debt
970
750
1 099
1 702
2 018
2 031
2 823
2 946
4 158
5 077
Current Portion of Long-Term Debt
0
0
29
29
5
5
1
906
982
1 056
Other Current Liabilities
72
73
135
154
245
315
545
771
969
1 811
Total Current Liabilities
1 679
1 541
2 194
2 997
3 414
4 003
5 468
7 176
9 708
11 454
Long-Term Debt
96
81
29
0
21
260
1 207
4 204
4 252
4 708
Minority Interest
75
0
25
50
49
92
188
457
652
1 109
Other Liabilities
15
15
15
23
15
77
83
20
18
29
Total Liabilities
1 865
N/A
1 637
-12%
2 263
+38%
3 070
+36%
3 499
+14%
4 432
+27%
6 947
+57%
11 857
+71%
14 629
+23%
17 299
+18%
Equity
Common Stock
200
360
360
400
400
540
659
791
949
1 139
Retained Earnings
229
624
910
1 385
1 677
2 140
2 874
2 933
3 573
4 170
Additional Paid In Capital
71
37
47
967
961
1 515
1 762
1 643
1 537
1 355
Treasury Stock
0
0
0
0
0
0
99
78
37
30
Other Equity
0
0
0
0
0
46
190
190
190
190
Total Equity
500
N/A
1 021
+104%
1 317
+29%
2 753
+109%
3 038
+10%
4 240
+40%
5 385
+27%
5 479
+2%
6 212
+13%
6 824
+10%
Total Liabilities & Equity
2 365
N/A
2 658
+12%
3 580
+35%
5 823
+63%
6 537
+12%
8 672
+33%
12 332
+42%
17 336
+41%
20 841
+20%
24 123
+16%
Shares Outstanding
Common Shares Outstanding
374
674
674
749
749
777
788
1 136
1 136
1 137

See Also

Discover More